Insys Therapeutics Inc.

(OTO:INSYQ)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Insys Therapeutics Inc is a specialty pharmaceutical company. It develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve patients' quality of life. The company have two marketed products; SUBSYS, a proprietary sublingual fentanyl spray; and SYNDROS, a proprietary orally administered liquid formulation of dronabinol. The company derives revenue from selling SUBSYS and SYNDROS in various dosing packages to wholesale pharmaceutical distributors and specialty retail pharmacies, on a wholesale basis.

Contact Information

Website: www.insysrx.com
Email: INSY@alpha-ir.com
Main Phone: +1 480 500-3127
Address: 1333 South Spectrum Boulevard
Address 2: Suite 100
State: AZ
City / Town: Chandler
Country: US
Postal Code: 85286

Issuer Information

Exchange: OTO
CEO: Andrew G. Long
Employees: 226
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A